The Patent Finder

Novel Tumor Biomarker

Tsinghua University

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 12/880,265, filed Sep 13, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,975,030Method for Cancer Detection
In force
 · High confidence
UsedRemaining
Protgen Ltd.In forceHigh confidence
US 9,815,906Method of Inhibiting or Treating Cancer Metastasis
In force
 · High confidence
Protgen Ltd.In forceHigh confidence
US 8,389,684Novel Tumor Biomarker
In force
 · Medium confidence
Tsinghua University and Protgen Ltd.In forceMedium confidence
US 9,364,493Methods and Compositions for Enhancing the Uptake of Therapeutic Agents by Target Cells
In force
 · High confidence
Beijing Protgen Ltd.In forceHigh confidence
US 9,200,306Methods for Production and Purification of Polypeptides
In force
 · High confidence
Tsinghua UniversityIn forceHigh confidence
US 10,647,968Endostatin Mutants with Mutations at Atp Binding Sites
In force
 · High confidence
Tsinghua UniversityIn forceHigh confidence
Application 17/277,661Nadh-Dependent Amino Acid Dehydrogenase and Application Thereof in Increasing Lysine Yield
Abandoned
Abandoned Nov 30, 2022
Tsinghua UniversityAbandonedAbandoned Nov 30, 2022
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Tsinghua University.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited